A Guideline for the Diagnosis of Pediatric Mitochondrial Disease: The Value of Muscle and Skin Biopsies in the Genetics Era

Abstract

Mitochondrial diseases are highly heterogeneous on the clinical, biochemical, and genetic level. In the traditional diagnostic approach (“biopsy first”) the evaluation of the affected individual and his body fluids, combined with the analysis of the respiratory chain enzymes in muscle based the subsequent Sanger sequencing of single candidate genes (“from function to gene”). Within the past few years, next-generation sequencing techniques of leucocyte-derived DNA (e.g., exome sequencing), with a diagnostic yield of more than 40%, have become the first line routine technology. This implicates that the invasive muscle biopsy is performed less often, especially in children. Furthermore, in this “genetics-first” approach the detection of new candidate genes precedes functional evaluations (“from gene to function”) leading to reverse phenotyping of affected individuals. Here, we line out the value of muscle and other tissue biopsies in this “genetics-first” era. We describe when and why it is still needed. We create awareness of pitfalls in the genetic diagnostics of mitochondrial diseases still necessitating tissue biopsies. Finally, we discuss why tissue biopsies are required for confirmatory diagnostics, or for getting a biochemical diagnosis in patients with hidden variants not detectable by standard genetics.

Keywords

exome sequencing - genome sequencing - next-generation sequencing - mitochondrial disease - mitochondrial DNA

Note

The study was financially supported by the E-Rare project GENOMIT (01GM1207 to H.P., Austrian Science Fonds [FWF]: I 2741-B26 to J.A.M.), the Vereinigung zur Förderung pädiatrischer Forschung und Fortbildung Salzburg.

• References

• 1 Schaefer AM, Taylor RW, Turnbull DM, Chinnery PF. The epidemiology of mitochondrial disorders--past, present and future. Biochim Biophys Acta 2004; 1659 (2-3): 115-120
• 2 Chinnery PF, Johnson MA, Wardell TM. , et al. The epidemiology of pathogenic mitochondrial DNA mutations. Ann Neurol 2000; 48 (02) 188-193
• 3 Skladal D, Halliday J, Thorburn DR. Minimum birth prevalence of mitochondrial respiratory chain disorders in children. Brain 2003; 126 (Pt 8): 1905-1912
• 4 Munnich A, Rötig A, Chretien D. , et al. Clinical presentation of mitochondrial disorders in childhood. J Inherit Metab Dis 1996; 19 (04) 521-527
• 5 Mayr JA, Haack TB, Graf E. , et al. Lack of the mitochondrial protein acylglycerol kinase causes Sengers syndrome. Am J Hum Genet 2012; 90 (02) 314-320
• 6 Wortmann SB, Ziętkiewicz S, Kousi M. , et al. CLPB mutations cause 3-methylglutaconic aciduria, progressive brain atrophy, intellectual disability, congenital neutropenia, cataracts, movement disorder. Am J Hum Genet 2015; 96 (02) 245-257
• 7 Wortmann SB, Vaz FM, Gardeitchik T. , et al. Mutations in the phospholipid remodeling gene SERAC1 impair mitochondrial function and intracellular cholesterol trafficking and cause dystonia and deafness. Nat Genet 2012; 44 (07) 797-802
• 8 Mayr JA, Haack TB, Freisinger P. , et al. Spectrum of combined respiratory chain defects. J Inherit Metab Dis 2015; 38 (04) 629-640
• 9 Wortmann SB, Koolen DA, Smeitink JA, van den Heuvel L, Rodenburg RJ. Whole exome sequencing of suspected mitochondrial patients in clinical practice. J Inherit Metab Dis 2015; 38 (03) 437-443
• 10 Neveling K, Feenstra I, Gilissen C. , et al. A post-hoc comparison of the utility of sanger sequencing and exome sequencing for the diagnosis of heterogeneous diseases. Hum Mutat 2013; 34 (12) 1721-1726
• 11 Haack TB, Haberberger B, Frisch EM. , et al. Molecular diagnosis in mitochondrial complex I deficiency using exome sequencing. J Med Genet 2012; 49 (04) 277-283
• 12 Kohda M, Tokuzawa Y, Kishita Y. , et al. A comprehensive genomic analysis reveals the genetic landscape of mitochondrial respiratory chain complex deficiencies. PLoS Genet 2016; 12 (01) e1005679
• 13 Lek M, Karczewski KJ, Minikel EV. , et al; Exome Aggregation Consortium. Analysis of protein-coding genetic variation in 60,706 humans. Nature 2016; 536 (7616): 285-291
• 14 Zhu J, Vinothkumar KR, Hirst J. Structure of mammalian respiratory complex I. Nature 2016; 536 (7616): 354-358
• 15 Sperl W, Fleuren L, Freisinger P. , et al. The spectrum of pyruvate oxidation defects in the diagnosis of mitochondrial disorders. J Inherit Metab Dis 2015; 38 (03) 391-403
• 16 Lake NJ, Compton AG, Rahman S, Thorburn DR. Leigh syndrome: One disorder, more than 75 monogenic causes. Ann Neurol 2016; 79 (02) 190-203
• 17 Aulbert W, Weigt-Usinger K, Thiels C. , et al. Long survival in Leigh syndrome: new cases and review of literature. Neuropediatrics 2014; 45 (06) 346-353
• 18 Thiels C, Fleger M, Huemer M. , et al. Atypical clinical presentations of TAZ mutations: an underdiagnosed cause of growth retardation?. JIMD Rep 2016; 29: 89-93
• 19 Wortmann SB, Kluijtmans LA, Rodenburg RJ. , et al. 3-Methylglutaconic aciduria--lessons from 50 genes and 977 patients. J Inherit Metab Dis 2013; 36 (06) 913-921
• 20 Baertling F, Klee D, Haack TB. , et al. The many faces of paediatric mitochondrial disease on neuroimaging. Childs Nerv Syst 2016; 32 (11) 2077-2083
• 21 Haack TB, Madignier F, Herzer M. , et al. Mutation screening of 75 candidate genes in 152 complex I deficiency cases identifies pathogenic variants in 16 genes including NDUFB9. J Med Genet 2012; 49 (02) 83-89
• 22 Hollegaard MV, Grauholm J, Nielsen R, Grove J, Mandrup S, Hougaard DM. Archived neonatal dried blood spot samples can be used for accurate whole genome and exome-targeted next-generation sequencing. Mol Genet Metab 2013; 110 (1-2): 65-72
• 23 Distelmaier F, Haack TB, Wortmann SB, Mayr JA, Prokisch H. Treatable mitochondrial diseases: cofactor metabolism and beyond. Brain 2017; 140 (Pt 2): e11
• 24 Horvath R, Hudson G, Ferrari G. , et al. Phenotypic spectrum associated with mutations of the mitochondrial polymerase gamma gene. Brain 2006; 129 (Pt 7): 1674-1684
• 25 Haack TB, Danhauser K, Haberberger B. , et al. Exome sequencing identifies ACAD9 mutations as a cause of complex I deficiency. Nat Genet 2010; 42 (12) 1131-1134
• 26 Kremer LS, Prokisch H. Identification of disease-causing mutations by functional complementation of patient-derived fibroblast cell lines. Methods Mol Biol 2017; 1567: 391-406
• 27 Kremer LS, Bader DM, Mertes C. , et al. Genetic diagnosis of Mendelian disorders via RNA sequencing. bioRxiv 2016 (e-pub ahead of print). doi: 10.1101/066738
• 28 Ferri L, Dionisi-Vici C, Taurisano R, Vaz FM, Guerrini R, Morrone A. When silence is noise: infantile-onset Barth syndrome caused by a synonymous substitution affecting TAZ gene transcription. Clin Genet 2016; 90 (05) 461-465